Altamira Therapeutics Ltd.
CYTOF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001601936
No open-market purchases or sales by Altamira Therapeutics Ltd. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Altamira Therapeutics Ltd. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 19 | 18 | −1 |
| Shares | 566.9K | 555.8K | −11.2K (−2.0%) |
| Value | $1.03M | $607.0K | −$421.0K (−41.0%) |
New holders (4)
Institutions that held Altamira Therapeutics Ltd. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 17,555 | $19.0K | 0.00% |
| 1832 Asset Management L.P. | 1,000 | $1.00K | 0.00% |
| Gradient Investments LLC | 1,000 | $1.00K | 0.00% |
| Barclays PLC | 1 | $0 | 0.00% |
Sold out (5)
Institutions that held Altamira Therapeutics Ltd. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Two Sigma Securities, LLC | 10,497 | $19.0K |
| Jane Street Group, LLC | 10,114 | $18.0K |
| Bank of America Corp | 1 | $0 |
| Cornerstone Advisory, LLC | 5 | $0 |
| Rockefeller Capital Management L.P. | 250 | $0 |